CA2976873A1 — Devices, systems, and methods for medicament delivery
Assigned to kaleo Inc · Expires 2006-08-10 · 20y expired
What this patent protects
An apparatus includes a housing associated with an automatic injection device and defining a status window. A contact member movably coupled to a distal end portion of the housing, includes a surface to place against a target location. An energy storage member within the housing …
USPTO Abstract
An apparatus includes a housing associated with an automatic injection device and defining a status window. A contact member movably coupled to a distal end portion of the housing, includes a surface to place against a target location. An energy storage member within the housing can exert force on a movable member to move the movable member within the housing to transition the apparatus from an initial configuration to an activated configuration. An electronic circuit system coupled to the housing, has a switch and a speaker, and produces recorded speech output when the switch is manipulated. A use indicator moves within the housing along with the movable member from a first to a second position when the contact member is in a fixed position relative to the housing, and provides a visual indication when the apparatus is in the activated configuration and the use indicator is in the second position.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.